Positive Clinical Results for Alzheimer’s Amyloid-Clearing Drug – Lecanemab Poised for FDA Approval
Positive results from new amyloid-clearing drug represent a starting point for Alzheimer’s treatment, while combination therapy remains the holy grail. Amyloid-clearing drug lecanemab will be…